Showing 5741-5750 of 5956 results for "".
- New STAIRWAY Study Data Shows Potential for Extended Durability with Faricimab in Wet AMDhttps://modernod.com/news/new-stairway-study-data-shows-potential-for-extended-durability-with-faricimab-in-wet-amd/2479728/Genentech announced positive results from the phase 2 STAIRWAY study which explored the extended durability of faricimab (RG7716) in the treatment of wet age-related macular degeneration (AMD). At 52 weeks, faricimab patients dosed either every 16 weeks or every 12 weeks demonstrated sustained vi
- Easier, Potentially More Effective Treatment for Blinding Eye Disease Shows Promise in Clinical Trialhttps://modernod.com/news/easier-potentially-more-effective-treatment-for-blinding-eye-disease-shows-promise-in-clinical-trial/2479730/A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments. This represents a vast improvement over the typical regimen of nearly monthly eye injections. The researchers involve
- GenSight Biologics Enrolls First Subject in PIONEER Phase 1/2 Trial of Retinitis Pigmentosa Drug Candidatehttps://modernod.com/news/gensight-biologics-enrolls-first-subject-in-pioneer-phase-1-2-trial-of-retinitis-pigmentosa-drug-candidate/2479731/GenSight Biologics announced that the first subject was treated in the first-in-man PIONEER phase I/II clinical trial of GS030 at the Moorfields Eye Hospital in London, United Kingdom. “We are thrilled to see our second lead program, GS030, now entering the clinic. This is a fantastic achi
- Oyster Point Announces Positive Results From Two Phase 2b Clinical Trials of Investigational Treatments for Dry Eye Diseasehttps://modernod.com/news/oyster-point-announces-positive-results-from-two-phase-2b-clinical-trials-of-investigational-treatments-for-dry-eye-disease/2479733/Oyster Point Pharma announced results from the ONSET and RAINIER studies, two separate phase 2b clinical trials evaluating the company’s novel therapies for the treatment of dry eye disease (DED). Both studies, presented at the Ophthalmology Innovation Summit (OIS) meeting in Chicago, demonstrate
- CheckedUp Announces Expanding Reach in Vision Care and New Product Features at the Point of Carehttps://modernod.com/news/checkedup-announces-expanding-reach-in-vision-care-and-new-product-features-at-the-point-of-care/2479734/CheckedUp announced several new product features to optimize their health care decision technology. With more than 5,000 eye care professionals in the CheckedUp network, the technology empowers patients during their health care journey by engaging and educating them about their care, preventions,
- International Innovators in Medical and Surgical Eye Health to Convene in Chicago to Advance Patient Carehttps://modernod.com/news/international-innovators-in-medical-and-surgical-eye-health-to-convene-in-chicago-to-advance-patient-care/2479737/Thousands of eye physicians and surgeons this week will convene in Chicago to attend AAO 2018, the American Academy of Ophthalmology’s 122nd annual meeting. This gathering is an opportunity to hear global leaders in medical and surgical eye care discuss issues affecting patients’ lives, from the
- Topcon Introduces Topcon Harmony and Triton Swept Source OCT at the 2018 AAOhttps://modernod.com/news/topcon-introduces-topcon-harmony-and-triton-swept-source-oct-at-the-2018-aao/2479746/Topcon will debut the Topcon Harmony ophthalmic data management system at the AAO meeting in Chicago. Harmony replaces Synergy and features a completely redesigned browser-based user interface that includes new features and vendor-neutral connectivity. “The last few months of hard work and
- Alcon to Showcase Latest Innovations at American Academy of Ophthalmology 2018 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-american-academy-of-ophthalmology-2018-annual-meeting/2479748/Alcon will showcase several advancements in ophthalmology through a robust booth presence, a series of live demonstrations, and interactive symposia during the American Academy of Ophthalmology (AAO) 2018 annual meeting, taking place October 27-30 in Chicago, IL. “We are very excited to e
- FDA Warns Against Using Raindrop Near Vision Inlayhttps://modernod.com/news/fda-warns-against-using-raindrop-near-vision-inlay/2479749/The FDA today issued an alert about an increased risk for corneal haze in patients with the Raindrop Near Vision Inlay (Optics Medical). The FDA issued the alert after 75% of patients in a postapproval study of the device developed corneal haze, according to a
- Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite on IBM Cloudhttps://modernod.com/news/bausch-lomb-to-launch-first-in-class-surgical-support-applications-for-stellaris-elite-on-ibm-cloud/2479752/Bausch + Lomb and IBM announced the launch of the new eyeTELLIGENCE applications which will run on the IBM Cloud to help eye surgeons and surgical facilities work more efficiently using Stellaris Elite vision enhancement systems. The companies built the eyeTELLIGENCE applications to deliver surge